ГоловнаArchive of numbers2018Volume 26, issue 3 (96)The value of proteins in liquor and blood serum in patients with progressive courses of multiple sclerosis
Title of the article The value of proteins in liquor and blood serum in patients with progressive courses of multiple sclerosis
Authors Vasylovskyi Vitalii
In the section MEDICO-PSYCHOLOGICAL, PATHOPSYCHOLOGICAL AND NARCOLOGICAL EFFECTS OF SOCIAL STRESS (DIAGNOSIS, PREVENTION, TREATMENT)
Year 2018 Issue Volume 26, issue 3 (96) Pages 72-77
Type of article Scientific article Index UDK 616.832-004.2:612.398.12-324.1 Index BBK -
Abstract We have studied the indexes of albumin’s value and IgG immunoglobulin in the blood serum and in the cerebrospinal fl uid in order to determine the peculiarities of functioning of bloodbrain barrier (BBB) in 280 patients within diff erent courses of multiple sclerosis. We assessed the value of albumin and IgG immunoglobulin considering the course of the disease, the stage of process’s activity (at stages of progression and stabilization), the gender-sensitive issue, the duration of the disease, the severity of neurological defi cit according to the EDSS scale. We have showed that the degree of BBB permeability predominantly related to the stage of the process’s activity. The BBB permeability was much less aff ected by the course of the disease. Such indicators as gender, the duration of the disease and the severity of neurological defi cit according to the EDSS scale actually do not have any infl uence.
Key words multiple sclerosis, blood-brain barrier, albumins, immunoglobulin G, course, process’s activity, gender factor, duration of the disease, neurological defi cit
Access to full text version of the article pdf download
Bibliography 1. Лиджиева Р. Ц. Специфи чес кие белки нервной ткани в оценке проницаемости ГЭБ при коматозных состояниях у де- тей : автореф. дис. на соискание уч. степени канд. мед. наук. М., 1990. 24 с. 2. Мищенко В. А., Горюхина O. A. Структура, проницаемость гематоэнцефали чес кого барьера и перспективы доставки через него лекарственных средств // Журнал неврологии и психиатрии. 1996. Т. 96, № 4. С. 116—128. 3. Bates D. A new look at the effectiveness of natalizumab in multiple sclerosis // International Journal of Neurological. 2011. No. 7 (46). С. 21—29. 4. Claudio L., Raine C. S., Brosnan C. F. Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis // Acta Neuropathology. 1995. Vol. 90, No. 3. P. 228—238. 5. Vascular aspects of multiple sclerosis / [M. D’haeseleer, M. Cambron, L. Vanopdenbosch, J. De Keyser] // The Lancet neurol. 2012. No. 8 (41). Р. 26—37. 6. Havla J., Gerdes L. A., Meinl I. De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate // J. Neurol. 2011. No. 58 (9). Р. 1665—1669. 7. Nag S. The Blood-Brain Barrier: Biology and Research Protocols // Springer, Methods in Molecular Biology. 2011. Vol. 686. Р. 518.